SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-033343
Filing Date
2020-02-12
Accepted
2020-02-12 16:48:33
Documents
2
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. III, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND III, L.P.POLARIS VENTURE PARTNERS FOUNDERS' FUND III, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13G d883952dsc13g.htm SC 13G 114107
2 EX-99.A d883952dex99a.htm EX-99.A 8359
  Complete submission text file 0001193125-20-033343.txt   124364
Mailing Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210 7812900770
POLARIS VENTURE PARTNERS III LP (Filed by) CIK: 0001104639 (see all company filings)

IRS No.: 043497143
Type: SC 13G

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88094 | Film No.: 20604890
SIC: 2834 Pharmaceutical Preparations